黑料官网

header-logo
GettyImages-758308167-hero
Biostatistics
Aniko Szabo, PhD

Aniko Szabo, PhD

Biostatistical Consulting Center Director and Professor

Locations

  • Biostatistics

Contact Information

Education

PhD, Applied Statistics, University of Memphis, Memphis, TN, 1998
MS, Statistics, University of Memphis, Memphis, TN, 1997
MS, Mathematics, E枚tv枚s University, Budapest, Hungary, 1994

Research Experience

  • Mathematical Modeling of Cancer Screening and Oncogenesis.

Leadership Positions

  • Director of the Biostatistics Consulting Center

Research Interests

Dr. Aniko Szabo is a professor and director of the Biostatistics Consulting Service. Dr. Szabo's research interests are in statistical modeling of biomedical data. She has worked on analysis methods for PCR and microarray data, developing tree models of oncogenesis, nonparametric models of clustered discrete data, and population level models of the effect of screening on prostate cancer incidence. She collaborates with biomedical investigators across the entire spectrum of translational research from analyzing cellular assays, animal experiments, and observational studies in patients to designing prospective clinical trials and evaluation of policy impacts in national databases.

Publications

  • (Wallisch E, Tomita-Mitchell A, Liang HL, Szabo A, Lenarczyk M, Kwitek A, Smith JR, Tutaj M, Baker JE.) J Radiat Res. 2025 Apr 30 PMID: 40304705 04/30/2025

  • (Mohan M, Szabo A, Cheruvalath H, Clennon A, Bhatlapenumarthi V, Patwari A, Balev M, Bhutani D, Shrestha A, Thanendrarajan S, Dhakal B, Zangari M, Trikannad A, Vellanki S, Al-Hadidi S, Lentzsch S, van Rhee F, Bag A, D'Souza A, Shah N, Chakraborty R, Shah MR, Schinke C.) Blood Cancer J. 2025 Apr 23;15(1):74 PMID: 40268898 PMCID: PMC12018942 04/24/2025

  • (Everson CA, Szabo A, Olsen CM, Glaeser BL, Raff H.) Sleep. 2025 Apr 20 PMID: 40253577 04/20/2025

  • (Chunara F, Lugo C, Osinski K, Shah MR, Shah N, Kent J, Mohyuddin GR, Radhakrishnan SV, Kaur G, Chakraborty R, Banerjee R, Rasche L, Schinke C, D'Souza A, Szabo A, Mohan M.) Blood Cancer J. 2025 Apr 08;15(1):61 PMID: 40199861 PMCID: PMC11979001 SCOPUS ID: 2-s2.0-105003231303 04/09/2025

  • (Naas CJ, Saleh HO, Engel TW 2nd, Gutterman DD, Szabo A, Grawey T, Weston BW, Monti CE, Baker JE, Labinski J, Tang L, Jasti J, Bartos JA, Kalra R, Yannopoulos D, Riccardo Colella M, Aufderheide TP.) Resuscitation. 2025 Apr;209:110567 PMID: 40057016 SCOPUS ID: 2-s2.0-105000556919 03/09/2025

  • (Shah NN, Colina AS, Johnson BD, Szabo A, Furqan F, Kearl T, Schneider D, Vargas-Cortes M, Schmeling JL, Dwinell MB, Palen K, Longo W, Hematti P, Zamora AE, Hari P, Bucklan D, Cunningham A, Hamadani M, Fenske TS.) J Clin Oncol. 2025 Mar 31:JCO2402158 PMID: 40163793 03/31/2025

  • (Carver TW, Peppard WJ, Gellings JA, Thapa R, Trevino C, Mantz-Wichman M, Peschman JR, Szabo A, Yang Y, Schroeder ME, Milia DJ, Elegbede AF, de Moya MA, de Roon-Cassini TA.) J Trauma Acute Care Surg. 2025 Mar 28 PMID: 40152587 SCOPUS ID: 2-s2.0-105002736919 03/28/2025

  • (Wildes MP, Higgins RM, Gould JC, Chunara F, Szabo A, Kindel TL.) Surg Obes Relat Dis. 2025 Mar 04 PMID: 40121141 SCOPUS ID: 2-s2.0-105000676545 03/23/2025

  • (Livschitz J, Melamed J, Donato B, Lee AY, Dong H, Szabo A, Tisol WB, Linsky PL, Gasparri MG, Johnstone DW.) Ann Thorac Surg Short Rep. 2025 Mar;3(1):201-205 PMID: 40098825 PMCID: PMC11910823 03/18/2025

  • (Corrao K, Umpierrez A, Treml A, Szabo A, Michaelis L, Runaas L, Murthy GSG, Abedin S, Carlson K, Kreuziger LB, Atallah E.) Haematologica. 2025 Jan 30 PMID: 39882645 01/30/2025

  • (Dhakal B, Hari P, Chhabra S, Szabo A, Lum LG, Glass DD, Park JH, Donato M, Siegel DS, Felizardo TC, Fowler DH.) J Immunother Cancer. 2025 Jan 28;13(1) PMID: 39875173 PMCID: PMC11781102 SCOPUS ID: 2-s2.0-85216937952 01/29/2025

  • (Lauer KK, Zhang D, Lunar L, Landry C, Welter J, Flemming K, Franco R, Siclovan D, Avdeev J, Woodson BT, Szabo A, Truwit JD, Hainsworth KR.) BMJ Open Qual. 2024 Nov 27;13(4) PMID: 39608972 PMCID: PMC11603732 SCOPUS ID: 2-s2.0-85211239870 11/29/2024

Publications of from the

© 2025 黑料官网.  All rights reserved.  | Terms and Privacy | Web Accessibility Statement

Non-Discrimination Statement
The 黑料官网 (黑料官网) is committed to fostering a diverse community of outstanding faculty, staff, and students, as well as ensuring equal educational opportunity, employment, and access to services, programs, and activities, without regard to an individual's race, color, national origin, religion, age, disability, sex, gender identity/expression, sexual orientation, marital status, pregnancy, predisposing genetic characteristic, or military status. Employees, students, applicants or other members of the 黑料官网 community (including but not limited to vendors, visitors, and guests) may not be subjected to harassment that is prohibited by law or treated adversely or retaliated against based upon a protected characteristic. 黑料官网’s policy as well as federal and state laws and regulations prohibit unlawful discrimination and harassment.

Notice of Compliance with Laws and Commitment to Civil Rights
The 黑料官网 is committed to full compliance with all applicable federal, state, and local laws and regulations in the pursuit of our missions. Consistent with recent federal guidance, we affirm our commitment to individual merit, fairness, and equal treatment in all aspects of academic and institutional decision-making. As part of this commitment, we are actively reviewing our policies and materials to ensure they align with federal nondiscrimination obligations.